BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.060
-0.030 (-2.75%)
At close: Apr 28, 2026, 4:00 PM EDT
1.070
+0.010 (0.94%)
Pre-market: Apr 29, 2026, 4:54 AM EDT
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $28.70 million as of April 29, 2026. Its market cap has increased by 218.88% in one year.
Market Cap
28.70M
Enterprise Value
109.94M
1-Year Change
218.88%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $167.60M to $28.70M, a decrease of -82.88%. That is a compound annual growth rate of -19.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 29.50M | -15.71% |
| Dec 31, 2025 | 35.00M | 118.75% |
| Dec 31, 2024 | 16.00M | -81.48% |
| Dec 29, 2023 | 86.40M | -85.65% |
| Dec 30, 2022 | 601.90M | 5.82% |
| Dec 31, 2021 | 568.80M | -49.48% |
| Dec 31, 2020 | 1.13B | 327.25% |
| Dec 31, 2019 | 263.50M | 336.26% |
| Dec 31, 2018 | 60.40M | -63.96% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cumberland Pharmaceuticals | 60.72M |
| Incannex Healthcare | 56.32M |
| InterCure | 47.13M |
| Zhengye Biotechnology Holding | 43.60M |
| Talphera | 38.79M |
| Rockwell Medical | 34.39M |
| Aytu BioPharma | 27.05M |
| China Pharma Holdings | 25.50M |